Hazel
Ordered peptides from Hazel? Mail in a sample (US only) and let us test it.
Test my supplyHazel's visible evidence is a recent Tirzepatide result with confirmed identity, 99.9% purity, and modest overfill. The catalog signal is extremely narrow and uncertainty-limited because it rests on one unlabeled vial with no batch identifier or customer/price corroboration, leaving consistency unproven.
The report separates an unidentified Hazel personal seller from a noisy Hazel Cheffy/ZMZ promotional ecosystem using packaging, domain, and registration clues. It also maps why buyers cannot authenticate a repeat purchase.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Hazel rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
13 Jun 2025 | Pass | Tirzepatide Hazel | lab name | View COA | |||
About Hazel test results from Finnrick
Hazel is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 1 test, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Hazel peptides in this dataset are Tirzepatide (1 test). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 1 recent test.
Ordered peptides from Hazel? Mail in a sample (US only) and let us test it.
Test my supply